INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo DYNA RISEDRONATE tablets

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

SCHEDULING STATUS:
no data

PROPRIETARY NAME
(and dosage form):

DYNA RISEDRONATE tablets

COMPOSITION:
DYNA RISEDRONATE 5 mg:Each tablet contains risedronate sodium hemipentahydtrate equivalent to
risedronate sodium 5,0 mg
DYNA RISEDRONATE 35 mg
: Each tablet contains risedronate sodium hemipentahydtrate equivalent to risedronate sodium 35,0 mg

ATC CLASSIFICATION:
no data

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
DYNA RISEDRONATE 5 mg: 42/3.2/0767
DYNA RISEDRONATE 35 mg: 42/3.2/0768

APPLICANT:
PHARMA DYNAMICS (PTY) LTD
http://www.pharmadynamics.co.za/

MANUFACTURER:
PHARMATHENS S.A., PALLINI, ATTIKIS, GREECE

AVAILABILITY
no data - please check with company.

DATE OF REGISTRATION:
05 December 2013

SOURCE: Government Gazette -
STAATSKOERANT, 13 JUNIE 2014 No. 37727
NOTICE 405 OF 2014 - MEDICINES CONTROL COUNCIL

Posted: July 2014

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014